Strides Arcolab has received approval from USFDA for injectables manufacturing at its Bangalore plant. This will help the company to enter into the lucrative steriles export market and may expect a export turnover of US$ 150 million. The company is manufacturing cephalosporin, penicillin and other injectables and has already received 14 steriles  approvals from USFDA and other applications are pending, which may be cleared later in a phased manner.

{backbutton}